DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q3 2024

SEC EDGAR SourceSEC Filings

Top Holdings375 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

3.1M$533.4M4.6%$63.22+176.88%
23 qtrssince 2019-Q1
Decreased
0

CRINETICS PHARMACEUTICALS IN

5.9M$300.7M2.6%$25.10+102.22%
18 qtrssince 2020-Q2
Decreased
0

TransMedics Group, Inc.

1.4M$226.4M1.9%$63.04+152.46%
10 qtrssince 2022-Q2
Decreased
0
IBNIBN
ADR

ICICI BANK LTD-SPON ADR

6.7M$199.3M1.7%$18.60+59.22%
23 qtrssince 2019-Q1
Increased
51

VAXCYTE INC

1.7M$196.7M1.7%$48.10+135.20%
11 qtrssince 2022-Q1
Decreased
0

MODINE MANUFACTURING CO

1.4M$186M1.6%$66.41+98.35%
8 qtrssince 2022-Q4
Increased
60

XENON PHARMACEUTICALS INC

4.6M$180.9M1.6%$27.43+40.91%
19 qtrssince 2020-Q1
Increased
50

FTAI AVIATION LTD

1.3M$178.3M1.5%$27.55+374.08%
7 qtrssince 2023-Q1
Decreased
0

AXON ENTERPRISE INC

418,304$167.2M1.4%$197.68+99.99%
20 qtrssince 2019-Q4
Decreased
0

APOGEE THERAPEUTICS INC

2.5M$148.8M1.3%$40.80+42.14%
5 qtrssince 2023-Q3
Increased
57

II-VI INC

1.5M$134.5M1.2%$71.58+25.50%
3 qtrssince 2024-Q1
Increased
55

MERCADOLIBRE INC

63,987$131.3M1.1%$1,590.46+29.82%
9 qtrssince 2022-Q3
Increased
77

SWEETGREEN INC

3.4M$121.1M1.0%$30.22+18.96%
3 qtrssince 2024-Q1
Increased
59

GLAUKOS CORP

861,607$112.3M1.0%$85.88+49.38%
6 qtrssince 2023-Q2
Increased
45

NATERA INC

882,729$112.1M1.0%$69.40+81.15%
9 qtrssince 2022-Q3
Decreased
0
GPCRGPCR
ADR

STRUCTURE THERAPEUTICS INC

2.5M$110.9M1.0%$38.67+7.97%
7 qtrssince 2023-Q1
Decreased
0
ITUBITUB
Preferred

ITAU UNIBANCO H-SPON PRF ADR

16.1M$107M0.9%$4.91+1.93%
3 qtrssince 2024-Q1
Increased
68
CYBRCYBRDelisted

CYBERARK SOFTWARE LTD

363,474$106M0.9%$186.06+52.04%
12 qtrssince 2021-Q4
Increased
45

FRESHPET INC

771,517$105.5M0.9%$92.44+46.85%
5 qtrssince 2023-Q3
Increased
45

MONDAY COM LTD

377,089$104.7M0.9%$163.17+66.68%
7 qtrssince 2023-Q1
Decreased
0
$11.6B
AUM
375
Positions
Q3 2024
Filing
Rating · 2.0
Quarterly Portfolio Change
+11%Q2'23$7.9B-3%Q3'23$7.7B+8%Q4'23$8.3B+21%Q1'24$10B+3%Q2'24$10.3B+13%Q3'24$11.6B
Activity profile
$ moved · Q3'24
New23%Increased34%Decreased18%Exited25%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q10%1-4Q18%1-2Y16%2Y+55%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $11.6B across 375 positions as of Q3 2024. Top holdings: TSM (4.6%), CRNX (2.6%), TMDX (1.9%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q3 2024 Summary

Active quarter - 101 new positions, 87 exits, 149 increased. Top move: MELI (INCREASED, conviction 77). Portfolio: $11.6B across 375 positions.

Top holdings by portfolio weight

Total AUM$12B
TSM4.58%
CRNX2.58%
TMDX1.94%
IBN1.71%
PCVX1.69%
MOD1.60%
XENE1.55%
FTAI1.53%
AXON1.44%
APGE1.28%
Other1.16%

Portfolio allocation by GICS sector

Sectors11
Healthcare24.16%
Industrials18.80%
Technology18.73%
Consumer Cyclical12.67%
Financial Services10.73%
Consumer Defensive3.92%
Basic Materials3.26%
Energy2.96%
Unknown2.00%
Communication Services1.97%
Other0.78%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Industrials, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record66
Conviction43
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 Q2 2026+4.1M shares+$90M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used